K-SAB Trial - Sotorasib Followed by SBRT to 1-3 Lesions in Advanced NSCLC With KRASG12C Mutation

Conditions: Non-small Cell Lung Cancer Metastatic Interventions: Radiation: Stereotactic body radiation therapy (SBRT); Drug: Temporary Stopping Sponsors: Karolinska University Hospital; Sahlgrenska University Hospital, Sweden; Amgen Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials